Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Viemed Healthcare, Inc.NASDAQ: VMD

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin narrows to 3.4%

Net margin was 3.4% in Q1 FY2026, down 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 5.2%, down 0.1 pp year over year. Over 3 fiscal years it widened by 1.0 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 3 analysts of 5.1% for the fiscal year ending Dec 2026, down from 5.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
3.4%-4.0 pp QoQ
Last fiscal yearDec 2025
5.5%+0.5 pp YoY
LTMMar 2026
5.2%-0.1 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.0 pp+1.3 pp+2.3 pp
1 year+0.5 pp-0.5 pp-1.0 pp
3 years+1.0 pp+0.9 pp-0.1 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
5.5%
Year-over-year change
+0.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's LTM Mar 2026 net margin of 5.2% is the 3rd highest of the 11 companies compared; the peer median is -62.9%.
  • Its year-over-year change of -0.1 pp is the 8th highest of 11, against a peer median of +5.4 pp.
  • Over three fiscal years its change of +1.0 pp compares with a peer median of +44.2 pp.
VMD Competitors Peer median
Net Margin for VMD and competitors
Company Period LTM level YoY 3-year change
SNWVSANUWAVE Health, Inc.LTM Mar 202636.2% +126.1 pp+88.3 pp
ELMDElectromed, Inc.LTM Mar 202614.1% +2.4 pp+6.2 pp
VMDViemed Healthcare, Inc.LTM Mar 20265.2% -0.1 pp+1.0 pp
INGNInogen, Inc.LTM Mar 2026-7.1% +1.0 pp+15.7 pp
SGHTSight Sciences, Inc.LTM Mar 2026-46.8% +16.4 pp+71.2 pp
MASS908 Devices Inc.LTM Mar 2026-62.1% -30.8 pp+6.4 pp
OMOutset Medical, Inc.LTM Mar 2026-63.7% +35.1 pp+72.9 pp
QTRXQuanterix CorporationLTM Mar 2026-71.9% -36.2 pp+17.1 pp
CVRXCVRx, Inc.LTM Mar 2026-89.1% +8.3 pp+90.3 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-576.1% -101.8 pp+650.8 pp
Peer median (excluding VMD) -62.9%+5.4 pp+44.2 pp

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue117.06M138.83M183.01M224.26M270.28M
Cost of Revenue43.65M54.15M70.23M91.05M114.82M
Gross Profit73.41M84.68M112.78M133.2M155.46M
Gross Margin62.7%61.0%61.6%59.4%57.5%
Research & Development2.11M2.7M2.78M3.07M3.02M
Selling, General & Admin60.04M73.36M93.73M112.48M130.5M
Operating Expenses61.83M76.43M98.45M115.3M134.75M
Depreciation & Amortization11.31M15.63M21.86M25.37M28.61M
EBITDA24.13M24.82M36.68M42.31M51.56M
EBITDA Margin20.6%17.9%20.0%18.9%19.1%
Operating Income11.58M8.25M14.33M17.9M20.71M
Operating Margin9.9%5.9%7.8%8.0%7.7%
Interest Income00000
Interest Expense318K197K424K776K1.18M
Other Income / Expenses923K738K61K(1.73M)1.06M
Income Before Tax12.5M8.99M14.39M16.17M21.77M
Pre-Tax Margin10.7%6.5%7.9%7.2%8.1%
Income Tax Expense3.38M2.77M4.15M4.76M6.39M
Net Income9.13M6.22M10.24M11.27M14.93M
Net Margin7.8%4.5%5.6%5.0%5.5%
EPS (Basic)0.230.150.270.290.38
EPS (Diluted)0.220.150.250.280.37
Weighted Avg Shares39.49M38.66M38.35M38.76M38.9M
Weighted Avg Shares (Diluted)40.68M39.81M40.38M40.81M40.82M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.